Nanomedicine in coronary artery disease

Nanomedicine is one of the most promising therapeutic modalities researchers are working on. It involves development of drugs and devices that work at the nanoscale (10–9 m). Coronary artery disease (CAD) is responsible for more than a third of all deaths in age group >35 years. With such a huge...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambesh, Paurush, Campia, Umberto, Obiagwu, Chukwudi, Bansal, Rashika, Shetty, Vijay, Hollander, Gerald, Shani, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414944/
https://www.ncbi.nlm.nih.gov/pubmed/28460774
http://dx.doi.org/10.1016/j.ihj.2017.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414944/
https://www.ncbi.nlm.nih.gov/pubmed/28460774
http://dx.doi.org/10.1016/j.ihj.2017.02.007

Ejemplares similares